OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives
Linda Silina, Fatlinda Maksut, Isabelle Bernard‐Pierrot, et al.
Cancers (2020) Vol. 13, Iss. 1, pp. 87-87
Open Access | Times Cited: 14
Linda Silina, Fatlinda Maksut, Isabelle Bernard‐Pierrot, et al.
Cancers (2020) Vol. 13, Iss. 1, pp. 87-87
Open Access | Times Cited: 14
Showing 14 citing articles:
Chitosan coated biocompatible zeolitic imidazolate framework ZIF-90 for targeted delivery of anticancer drug methotrexate
Xiang-Xin Cao, Shui-Li Liu, Jing-Sheng Lu, et al.
Journal of Solid State Chemistry (2021) Vol. 300, pp. 122259-122259
Closed Access | Times Cited: 33
Xiang-Xin Cao, Shui-Li Liu, Jing-Sheng Lu, et al.
Journal of Solid State Chemistry (2021) Vol. 300, pp. 122259-122259
Closed Access | Times Cited: 33
Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Gonzalo Rodríguez‐Berriguete, Marco Ranzani, Remko Prevo, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 8, pp. 1631-1642
Open Access | Times Cited: 15
Gonzalo Rodríguez‐Berriguete, Marco Ranzani, Remko Prevo, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 8, pp. 1631-1642
Open Access | Times Cited: 15
Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling
Yu‐Chieh Tsai, Tzu-Yin Wang, Chia‐Lang Hsu, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 9, pp. 1753-1764
Open Access | Times Cited: 15
Yu‐Chieh Tsai, Tzu-Yin Wang, Chia‐Lang Hsu, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 9, pp. 1753-1764
Open Access | Times Cited: 15
EZH2 targeting to improve the sensitivity of acquired radio-resistance bladder cancer cells
Xiangyan Zhang, Xiangli Ma, Quanxin Wang, et al.
Translational Oncology (2021) Vol. 16, pp. 101316-101316
Open Access | Times Cited: 13
Xiangyan Zhang, Xiangli Ma, Quanxin Wang, et al.
Translational Oncology (2021) Vol. 16, pp. 101316-101316
Open Access | Times Cited: 13
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation
Linda Silina, Florent Dufour, Audrey Rapinat, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8671-8671
Open Access | Times Cited: 5
Linda Silina, Florent Dufour, Audrey Rapinat, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8671-8671
Open Access | Times Cited: 5
Differential expression of DNA damage repair genes after chemoradiotherapy and inhibition rate in different bladder cancer cells
Shujun Sun, Kehua Jiang, Jin Zeng
Translational Andrology and Urology (2022) Vol. 11, Iss. 9, pp. 1336-1344
Open Access | Times Cited: 4
Shujun Sun, Kehua Jiang, Jin Zeng
Translational Andrology and Urology (2022) Vol. 11, Iss. 9, pp. 1336-1344
Open Access | Times Cited: 4
Case report: Bladder preserving after maximal transurethral resection of the bladder tumor combined with chemotherapy and immunotherapy in recurrent muscle-invasive bladder cancer patients: A report of two cases
Jiaquan Mao, Chunguang Yang, Xin Sheng, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 3
Jiaquan Mao, Chunguang Yang, Xin Sheng, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 3
Risk and prognosis of secondary malignant neoplasms after radiation therapy for bladder cancer: A large population-based cohort study
Ru Chen, Xiangpeng Zhan, Haoxin Jiang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Ru Chen, Xiangpeng Zhan, Haoxin Jiang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model
Jiamin Huang, Éva Michaud, Surashri Shinde-Jadhav, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access
Jiamin Huang, Éva Michaud, Surashri Shinde-Jadhav, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access
Three-in-One Nanozyme for Radiosensitization of Bladder Cancer
Yang Li, Yuhan Zhang, Na Feng, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 10873-10883
Open Access
Yang Li, Yuhan Zhang, Na Feng, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 10873-10883
Open Access
Editorial: Recent advances in the treatment of upper urinary tract bladder cancers
Łukasz Zapała, Aleksander Ślusarczyk
Frontiers in Urology (2023) Vol. 3
Open Access | Times Cited: 1
Łukasz Zapała, Aleksander Ślusarczyk
Frontiers in Urology (2023) Vol. 3
Open Access | Times Cited: 1
Urological Cancer Panorama in the Second Year of the COVID-19 Pandemic
E. López-Anglada Fernández, J.C. Angulo, José I. López, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 493-493
Open Access | Times Cited: 1
E. López-Anglada Fernández, J.C. Angulo, José I. López, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 493-493
Open Access | Times Cited: 1
Data from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Gonzalo Rodríguez‐Berriguete, Marco Ranzani, Remko Prevo, et al.
(2023)
Open Access
Gonzalo Rodríguez‐Berriguete, Marco Ranzani, Remko Prevo, et al.
(2023)
Open Access
Data from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Gonzalo Rodríguez‐Berriguete, Marco Ranzani, Remko Prevo, et al.
(2023)
Open Access
Gonzalo Rodríguez‐Berriguete, Marco Ranzani, Remko Prevo, et al.
(2023)
Open Access
